REVIEW
|
doi:10.20944/preprints201810.0010.v1
Subject:
Medicine And Pharmacology,
Ophthalmology
Keywords:
Gene therapy, gene editing, CRISPR/Cas9, Cas12a, dual AAV, triple AAV, clinical trials, retina, hereditary retinal dystrophies
Online: 1 October 2018 (13:52:23 CEST)